Researchers at the Johns Hopkins Bloomberg School of Public Health are making strides in addressing racial disparities in cancer outcomes. Avonne Connor, PhD, MPH, assistant professor in the Department of Epidemiology, is leading efforts to understand the biological, environmental, and social factors contributing to higher cancer mortality rates among African Americans.
“We know that African Americans have the highest death rate and shortest survival of any racial and ethnic group in the U.S. for most cancers,” said Connor. “My research aims to identify the root causes of these disparities and develop targeted interventions to improve cancer prevention, early detection, and treatment in underserved communities.”
Connor’s work focuses on breast, prostate, and colorectal cancers, which disproportionately affect African Americans. By analyzing large datasets and conducting community-based participatory research, her team is uncovering the complex interplay of genetics, lifestyle, access to care, and socioeconomic status that influence cancer risk and outcomes.
The Bloomberg School’s commitment to health equity is reflected in its diverse faculty and student body. However, Connor notes that more work is needed to increase representation of minorities in cancer research and clinical trials.
“Addressing cancer disparities requires a multifaceted approach,” said Connor. “By diversifying the research workforce, engaging communities, and translating findings into policy and practice, we can make progress toward closing the gap in cancer outcomes and ensuring that all individuals, regardless of race or ethnicity, have an equal opportunity to live healthy, cancer-free lives.”
See “World Cancer Day: How Bloomberg School Researchers are Confronting Cancer” (January 31, 2024)
